secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0000950170-25-089978
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma receives Nasdaq minimum bid price deficiency notice; has until Dec 17, 2025 to cure
--------------------------------------------------------------------------------

- Nasdaq notified Sutro on June 20, 2025 of non-compliance with $1.00 minimum bid price rule.
- Company has 180 calendar days, until December 17, 2025, to regain compliance by closing at $1.00 for 10 consecutive days.
- If not cured, Sutro may transfer to Nasdaq Capital Market for a second 180-day period or face delisting.
- Sutro plans to monitor bid price and may implement a reverse stock split if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017025089978/0000950170-25-089978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017025089978/stro-20250620.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-089978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer